Approved indications:

• Reducing the risk of major cardiovascular events (cardiovascular death, heart attack, stroke, or certain arterial procedures) in adults without established coronary heart disease who are at increased risk.
• As an adjunct to diet to reduce LDL cholesterol in adults with primary hyperlipidemia, and to reduce LDL and slow progression of atherosclerosis in adults.
• As an adjunct to diet to reduce LDL cholesterol in adults and pediatric patients 8 years and older with heterozygous familial hypercholesterolemia (HeFH).
• As an adjunct to other LDL‑lowering therapies, or alone if such treatments are unavailable, to reduce LDL cholesterol in adults and pediatric patients 7 years and older with homozygous familial hypercholesterolemia (HoFH).
• As an adjunct to diet for treatment of adults with hypertriglyceridemia and with primary dysbetalipoproteinemia (Type III hyperlipoproteinemia).

Off‑label uses and evidence:

• Widely used as part of high‑intensity statin therapy in people with established atherosclerotic cardiovascular disease (secondary prevention), supported by large outcome trials showing statins, including rosuvastatin, reduce recurrent events.
• Often chosen when very large LDL reductions are needed or when patients have not reached targets on other statins, based on comparative studies showing strong LDL‑lowering potency.

Efficacy expectations:

• LDL cholesterol usually begins to fall within 1–2 weeks, with near‑maximal effect about 4 weeks after starting or changing the dose.
• Moderate doses can lower LDL by roughly 40–50%, and high‑intensity doses (20–40 mg daily in many adults) often lower LDL by 50% or more.
• In high‑risk adults, rosuvastatin has been shown to significantly reduce major cardiovascular events compared with placebo, and for LDL lowering it is at least as potent as, and sometimes more potent than, equivalent doses of many other statins.

How to take it:

• Take rosuvastatin by mouth once daily, at the same time each day, with or without food.
• Swallow tablets whole with water; do not crush, chew, or split them.
• If you use an aluminum/magnesium hydroxide antacid, take rosuvastatin at least 2 hours before the antacid so absorption is not reduced.

Typical adult dosing:

• General dosing range: 5–40 mg once daily, individualized based on LDL level and cardiovascular risk.
• Usual starting dose for most adults is 10–20 mg once daily; cholesterol is rechecked about 4 weeks after starting or adjusting the dose.
• For adults with homozygous familial hypercholesterolemia, the usual starting dose is 20 mg once daily, and if needed it may be increased up to 40 mg once daily.
• The 40 mg dose is reserved for adults who have not reached their LDL goal on 20 mg and who do not have risk factors for muscle toxicity.

Typical pediatric dosing (familial hypercholesterolemia):

• HeFH, 8 to <10 years: 5–10 mg once daily.
• HeFH, 10–17 years: 5–20 mg once daily.
• HoFH, 7–17 years: 20 mg once daily.

Special dosing considerations:

• Severe renal impairment (not on hemodialysis): start at 5 mg once daily and do not exceed 10 mg once daily.
• Asian ancestry: start at 5 mg once daily because blood levels tend to be higher; use caution with doses above 20 mg.
• Certain interacting drugs (such as cyclosporine, gemfibrozil, some HIV or hepatitis C antivirals, and specific cancer therapies) require lower maximum rosuvastatin doses or should be avoided together; your prescriber will adjust the dose if these are used.

Missed dose: If you miss a dose, take it as soon as you remember that day unless it is almost time for your next dose; if it is close to the next dose, skip the missed tablet and resume your regular schedule—do not take two doses at once.

Overdose: In case of overdose, seek emergency medical care or contact a poison control center (1‑800‑222‑1222 in the U.S.); there is no specific antidote, so treatment focuses on monitoring and managing symptoms.

Common side effects (usually mild):

• Muscle aches, joint pain, or back pain, often occurring in the first weeks or after a dose increase; these are usually mild and reversible when the dose is lowered or the drug is stopped.
• Headache, nausea, stomach pain, constipation, or weakness, which typically improve as the body adjusts.
• Small increases in blood sugar or hemoglobin A1c, which may unmask a tendency toward diabetes in some people.

Serious or rare adverse effects needing immediate medical attention:

• Severe muscle problems (myopathy or rhabdomyolysis) with symptoms such as intense muscle pain or tenderness, unusual weakness, dark or cola‑colored urine, or fever.
• Liver injury, signaled by unusual fatigue, loss of appetite, right‑upper‑abdominal pain, dark urine, or yellowing of the skin or eyes.
• Allergic reactions including swelling of the face, lips, tongue, or throat, difficulty breathing, or widespread rash or hives.
• Very rare immune‑mediated muscle damage or memory changes/confusion, which generally improve after stopping the drug.

Warnings and precautions:

• Pregnancy and breastfeeding: rosuvastatin can harm a developing baby and passes into breast milk; it should not be used during pregnancy or while breastfeeding, and should be stopped if pregnancy occurs.
• Age and kidney function: older adults (especially ≥65 years) and people with kidney problems have a higher risk of muscle injury and may need lower maximum doses.
• Liver disease: avoid use in active liver disease or with persistent unexplained elevations in liver enzymes.
• Other risk factors for muscle problems include uncontrolled hypothyroidism, personal or family history of statin‑related muscle issues, and use with certain interacting drugs (such as gemfibrozil, some antivirals, or cyclosporine).

Overall safety compared with other statins: Rosuvastatin’s overall safety profile is similar to other statins, with rare serious muscle or liver events; it has fewer CYP3A4‑related drug interactions than statins like simvastatin or atorvastatin, but higher doses (especially 40 mg) carry more risk of muscle problems in susceptible patients.

Reporting side effects and safety updates: Side effects can be reported to the U.S. Food and Drug Administration (FDA) through the MedWatch program (online or by calling 1‑800‑FDA‑1088), and updated safety information is available on the FDA and manufacturer websites.

Major drug interactions:

• Cyclosporine markedly increases rosuvastatin levels; the rosuvastatin dose should be very low (maximum about 5 mg daily) or the combination avoided.
• Gemfibrozil substantially raises the risk of serious muscle injury; avoid if possible, and if used, only very low rosuvastatin doses are recommended.
• Other fibrates and high‑dose niacin can also increase muscle‑related side effects when combined with rosuvastatin.
• Certain HIV and hepatitis C antivirals (for example, protease inhibitor–containing regimens) and some targeted cancer drugs (such as darolutamide, regorafenib, and others) can raise rosuvastatin levels, so the maximum allowable rosuvastatin dose is reduced or the combination may be avoided.

Other medicines and supplements:

• Blood thinners (such as warfarin) may be affected slightly by rosuvastatin, so clotting tests (INR) may need closer monitoring when starting or changing the dose.
• Other cholesterol‑lowering drugs (ezetimibe, bile acid sequestrants) can be safely combined but may add to muscle or gastrointestinal side effects; dosing times may need to be separated for bile acid sequestrants.
• Antacids containing aluminum and magnesium can reduce rosuvastatin absorption if taken together; take rosuvastatin at least 2 hours before these antacids.
• Supplements that act like statins, such as red yeast rice, may increase the risk of muscle and liver side effects and are generally best avoided with rosuvastatin.

Food, alcohol, and lifestyle:

• Grapefruit juice does not have a significant interaction with rosuvastatin, unlike some other statins, so moderate intake is typically acceptable.
• Heavy alcohol use can increase the risk of liver problems; limit alcohol and avoid binge drinking while on rosuvastatin.
• A heart‑healthy diet, regular exercise, smoking cessation, and weight management greatly enhance the cholesterol‑lowering and cardiovascular benefits of rosuvastatin.

Conditions requiring extra caution:

• Active liver disease or unexplained persistent elevation of liver enzymes.
• Severe kidney impairment, history of statin‑related muscle problems, or inherited muscle disorders.
• Age ≥65 years, uncontrolled hypothyroidism, or frailty, which all increase muscle‑toxicity risk.
• Pregnancy and breastfeeding: rosuvastatin should not be used; effective contraception is recommended for people who could become pregnant while taking it.

Monitoring:

• Fasting or non‑fasting lipid panels at baseline, then about 4–12 weeks after starting or changing the dose, and periodically thereafter to ensure goals are met.
• Baseline liver enzymes (ALT/AST), with repeat testing if symptoms suggest liver trouble or if clinically indicated.
• Creatine kinase (CK) level if significant muscle pain, weakness, or dark urine develops.
• Blood sugar or hemoglobin A1c in people at risk for diabetes, since statins can slightly increase glucose levels.

Q: How long does it take for rosuvastatin to start lowering my cholesterol?
A: Many people see a drop in LDL cholesterol within 1–2 weeks, and the full effect of a given dose is usually reached by about 4 weeks, when your clinician may recheck labs and adjust the dose if needed.

Q: Is it better to take rosuvastatin in the morning or at night?
A: Rosuvastatin works well when taken at any time of day because of its long action, so you can take it at the time that best fits your routine, as long as you take it consistently once each day.

Q: What should I do if I develop muscle pain while taking this medicine?
A: Mild soreness is common, but if you notice new, persistent, or severe muscle pain, weakness, or dark urine, contact your healthcare professional promptly; they may check blood tests, adjust the dose, switch statins, or stop the drug depending on the findings.

Q: Can I drink alcohol while taking rosuvastatin?
A: Occasional light alcohol use is generally acceptable, but heavy or frequent drinking increases the risk of liver problems, so it is best to limit alcohol and discuss your typical intake with your prescriber.

Q: Can I stop rosuvastatin once my cholesterol numbers look normal?
A: Cholesterol usually rises again if a statin is stopped, so most people need long‑term treatment; any decision to reduce or stop rosuvastatin should be made with your clinician based on your cardiovascular risk and treatment goals.

Storage: Store rosuvastatin tablets at room temperature (about 68–77°F / 20–25°C), in the original tightly closed container, protected from moisture and excessive heat, and out of reach of children and pets.

Handling: Do not use tablets that are chipped, discolored, or past the expiration date, and avoid keeping the bottle in bathrooms, kitchens near the stove, or cars where temperature and humidity can fluctuate.

Disposal:

• Use a community medicine take‑back program or pharmacy mail‑back service when available.
• If no take‑back option exists, mix unused tablets with an unappealing substance (such as used coffee grounds or cat litter), place the mixture in a sealed bag or container, and throw it in the household trash.
• Remove or scratch out any personal information on empty pill bottles or packaging before discarding them.